Targeted Therapies in the Treatment of Vestibular Schwannomas: Current State and New Horizons

被引：5
|
作者：
Welling, D. Bradley [1 ,2 ,3 ]
机构：
[1] Harvard Dept Otolaryngol Head & Neck Surg, 243 Charles St, Boston, MA 02115 USA
[2] Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA
[3] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA | 2023年 / 56卷 / 03期
关键词：
Vestibular schwannoma; NF2-related schwannomatosis; Neurofibromatosis type 2; Pharmacotherapy; Acoustic neuroma; Bevacizumab; Molecular-targeted therapy; ENDOTHELIAL GROWTH-FACTOR; PHASE-II; NEUROFIBROMATOSIS TYPE-2; SPINAL EPENDYMOMAS; ASPIRIN INTAKE; NF2; EVEROLIMUS; GENE; BEVACIZUMAB; HEARING;
D O I：
10.1016/j.otc.2023.02.013
中图分类号：
R76 [耳鼻咽喉科学];
学科分类号：
100213 ;
摘要：
[No abstract available]
引用
收藏
页码：543 / 556
页数：14
相关论文
共 50 条
  • [21] A Critical Overview of Targeted Therapies for Vestibular Schwannoma
    Tamura, Ryota
    Toda, Masahiro
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (10)
  • [22] New-targeted therapies for glioblastoma treatment
    Marantidou, A.
    Carpentier, A.
    ONCOLOGIE, 2009, 11 (02) : 72 - 77
  • [23] New horizons in osteoporosis therapies
    Harslof, Torben
    Langdahl, Bente L.
    CURRENT OPINION IN PHARMACOLOGY, 2016, 28 : 38 - 42
  • [24] New horizons in cellular therapies
    Rebulla, P
    Pacchiana, R
    Montemurro, T
    Giordano, R
    Lecchi, L
    Porretti, L
    Lazzari, L
    CELLULAR ENGINEERING AND CELLULAR THERAPIES, 2003, 38 : 189 - 201
  • [25] Treatment Time Effect on Prescription Dose in the Treatment of Vestibular Schwannomas
    Singh, K.
    Han, C.
    Fleming, J. L.
    McElroy, J.
    Showalter, C. A.
    Manring, H.
    Hague, J.
    Chakravarti, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E273 - E273
  • [26] Treatment Time Effect on Prescription Dose in the Treatment of Vestibular Schwannomas
    Skinner, Matthew G.
    Weinstein, Lauren J.
    Paddick, Ian
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S5350 - S5353
  • [27] Current surgical results of retrosigmoid approach in extralarge vestibular schwannomas
    Jung, S
    Kang, SS
    Kim, TS
    Kim, HJ
    Jeong, SK
    Kim, SC
    Lee, JK
    Kim, JH
    Kim, SH
    Lee, JH
    SURGICAL NEUROLOGY, 2000, 53 (04): : 370 - 377
  • [28] Current Concepts in Management of Vestibular Schwannomas in Neurofibromatosis Type 2
    Tysome J.R.
    Axon P.R.
    Donnelly N.P.
    Durie-Gair J.
    Gareth Evans D.
    Ferner R.E.
    Macfarlane R.
    Mannion R.
    Nduka C.
    Morris K.
    Pretorius P.M.
    Rands G.
    Rowe J.
    Taylor A.
    Current Otorhinolaryngology Reports, 2014, 2 (4) : 248 - 255
  • [29] Treatment of vestibular schwannomas. Why, when and how?
    Myrseth, E.
    Pedersen, P.-H.
    Moller, P.
    Lund-Johansen, M.
    ACTA NEUROCHIRURGICA, 2007, 149 (07) : 647 - 660
  • [30] Subtotal/near-total treatment of vestibular schwannomas
    Gurgel, Richard K.
    Theodosopoulos, Philip V.
    Jackler, Robert K.
    CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY, 2012, 20 (05): : 380 - 384
12345